FDA Advisory Committee Rejects Pharmaxis’ Bronchitol for Cystic Fibrosis February 28, 2013 Filed under: Trends-in-Medicine
FDA ADVISORY COMMITTEE REJECTS PHARMAXIS’ BRONCHITOL FOR CYSTIC FIBROSIS February 28, 2013 Filed under: Trends-in-Medicine
FDA Holds Public Hearing on Approved Opioid Labeling February 25, 2013 Filed under: Trends-in-Medicine
FDA Advisory Committee Recommends Approval of Boehringer Ingelheim’s Striverdi Respimat (olodaterol) For COPD February 21, 2013 Filed under: Trends-in-Medicine
MEDCAC Rejects Beta-Amyloid PET Imaging for Alzheimer’s Disease February 12, 2013 Filed under: Trends-in-Medicine